said John T. Treace, CEO, Founder and Board Member of Treace. Surgeon design team member, Amber Shane, DPM, FACFAS, Department Chair and Residency Faculty at AdventHealth commented, “The ...

CEO John T. Treace expressed excitement about this new offering as a step towards broadening access to effective minimally invasive surgery. Full commercialization is expected in the second half ...

“We close 2024 with new product announcements and 12% annual revenue growth – positioning us for continued growth in 2025 and beyond,” said John T. Treace, CEO, Founder and Board Member of ...

"We're excited to expand our best-in-class bunion-focused portfolio with the SpeedAkin implant, furthering our commitment to improving patient outcomes," said John T. Treace, CEO, Founder ...

The company was founded by John T. Treace in July 2013 and is headquartered in Ponte Vedra Beach, FL.

announces that it is investigating claims on behalf of investors of Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ:TMCI) for violations of the securities laws. The investigation ...

“The SpeedAkin™ implant leverages our proprietary SpeedPlate™ technology in a differentiated Akin osteotomy solution, further expanding our best-in-class bunion focused portfolio.” said John T. Treace ...

"We close 2024 with new product announcements and 12% annual revenue growth - positioning us for continued growth in 2025 and beyond,” said John T. Treace, CEO, Founder and Board Member of Treace.